Prmt5 inhibition or deletion in CD4+ T cells has been reported to ameliorate experimental autoimmune encephalomyelitis (EAE), but the detailed molecular mechanisms have not yet been elucidated. This evidence concerns the gene PRMT5 and experimental autoimmune encephalomyelitis.